Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritalin for Emergence from Propofol Sedation
NCT03610282Phase 2Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2019
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate in Anesthesia emergence, sponsored by Massachusetts General Hospital. Planned start Nov 2019; status: withdrawn.
02
Drugs
methylphenidate
03
Conditions
Anesthesia emergence
Beyond the preview
Go deeper on NCT03610282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03610282.